RxDoctor Payments Data

Brady Rhodes, DPM

Podiatrist · Fort Worth, TXNPI 1245650050

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $67,200 of the $109,822 with a category attached, or 61.2%. Stryker accounts for 95.9% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2024 at $32,779 and has fallen 66.7% since, to $10,907 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$109,822in general payments, 2019–2025

Across 376 payments — averaging $292.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$105K
  • Smith+Nephew$778
  • Integra Lifesciences Corporation$646
  • Bioventus LLC$513
  • Pylant Medical$477
  • Polynovo North America LLC$324
  • plus $2K from 21 others

What the payments were for

  • Consulting fees$67,20061%
  • Travel & lodging$29,17627%
  • Food & beverage$13,19912%
  • Other$2470%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$109,822 in reported general payments places this provider in the 95th percentile of 470 podiatrist providers in Texas.

See all podiatrist providers in Texas

Medicare billing

Part B allowed, 2024
$53,958
Medicare patients
143
Services billed
457

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate33$338
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$331
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$139
Cephalexin15$129

Paid to pharmacies, not to this prescriber.

Other podiatrist in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →